Drugs / SIILPCV10
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02308540 | Jan 2015 → Apr 2016 | pneumococcal infection | PATH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SIILPCV 10 | “Infant Booster Dose SIILPCV 10” NCT02308540 ↗ |
| Known as | SIIPL-PCV | “Serum Institute of India Pvt. Ltd.'s PCV candidate (SIIPL-PCV) has the potential to meet this need” PMID 31843266 ↗ Dec 2019 |
| Modality | Vaccine | “10-valent Pneumococcal Conjugate Vaccine” NCT02308540 ↗ |